Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Potentiation01:35

Long-term Potentiation

Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental pharmacology-Dosing the environment: IUPHAR review 36.

British journal of pharmacology·2022
Same author

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.

The New England journal of medicine·2018
Same author

Nerve agents in honey.

Science (New York, N.Y.)·2017
Same author

Neuronal networks provide rapid neuroprotection against spreading toxicity.

Scientific reports·2016
Same author

Neonicotinoids target distinct nicotinic acetylcholine receptors and neurons, leading to differential risks to bumblebees.

Scientific reports·2016
Same author

Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2016

Related Experiment Video

Updated: Jul 9, 2026

Live Imaging of the Mitochondrial Glutathione Redox State in Primary Neurons using a Ratiometric Indicator
07:47

Live Imaging of the Mitochondrial Glutathione Redox State in Primary Neurons using a Ratiometric Indicator

Published on: October 20, 2021

Dendritic and mitochondrial changes during glutamate excitotoxicity.

Sam M Greenwood1, Christopher N Connolly

  • 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, UK.

Neuropharmacology
|November 23, 2007
PubMed
Summary

Excess extracellular glutamate in the central nervous system (CNS) causes excitotoxicity, damaging neurons. This review covers mechanisms of mitochondrial dysfunction and dendritic swelling, and how neurons recover from glutamate excitotoxicity.

More Related Videos

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

Related Experiment Videos

Last Updated: Jul 9, 2026

Live Imaging of the Mitochondrial Glutathione Redox State in Primary Neurons using a Ratiometric Indicator
07:47

Live Imaging of the Mitochondrial Glutathione Redox State in Primary Neurons using a Ratiometric Indicator

Published on: October 20, 2021

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system (CNS).
  • Elevated extracellular glutamate during CNS injury or disease leads to excitotoxicity, a form of neuronal cell death.
  • Excitotoxicity results from over-activation of ionotropic glutamate receptors.

Purpose of the Study:

  • To review the mechanisms underlying early excitotoxic events in neurons.
  • To explore the processes involved in dendritic recovery after excitotoxic insults.
  • To summarize current knowledge on glutamate-induced neuronal damage and repair.

Main Methods:

  • Literature review of existing research on excitotoxicity.
  • Analysis of mechanisms of mitochondrial dysfunction (e.g., depolarization, ATP depletion, pore opening).
  • Examination of the formation of dendritic varicosities/beads as a hallmark of toxicity.

Main Results:

  • Early signs of excitotoxicity include mitochondrial dysfunction and dendritic swelling (varicosities).
  • Mechanisms involve glutamate receptor over-activation, leading to cellular damage.
  • Dendritic recovery pathways are activated upon cessation of the excitotoxic stimulus.

Conclusions:

  • Understanding excitotoxicity mechanisms is crucial for developing neuroprotective strategies.
  • Mitochondrial health and dendritic integrity are key factors in neuronal survival after injury.
  • Further research into recovery mechanisms may reveal therapeutic targets for CNS disorders.